Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents - Kandzari, David E.; Koolen, Jacques J.; Doros, Gheorghe; Massaro, Joseph J.; Garcia-Garcia, Hector M.; Bennett, Johan; Roguin, Ariel; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron (Journal of the American College of Cardiology, 2018)
Keywords: Acute coronary syndromes; Angina pectoris; bioresorbable polymer; Cardiology; Cardiovascular; Clinical outcomes; Coronary artery; Coronary vessels; Drug delivery; drug-eluting stent; Heart attacks; Implants; Inhibitor drugs; Ischemia; Laboratories; Medical imaging; Myocardial infarction; Patients; percutaneous coronary intervention; Polymers; Rapamycin; Safety; sirolimus; Stents; Studies; Thrombosis; RR; bioresorbable polymer; drug-eluting stent; CI; CK-MB; TLF; percutaneous coronary intervention; DES; MACE; sirolimus; BP SES; TLR; MI; CMH; DP EES; myocardial infarction; drug-eluting stent(s); Cochran-Mantel-Haenszel; creatine kinase-myocardial band; durable polymer everolimus-eluting stent; target lesion revascularization; bioresorbable polymer sirolimus-eluting stent; major adverse cardiac event(s); relative risk; confidence interval; target lesion failure